Bank Maspion Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Maspion Indonesia Tbk. trades at Rp476 (market cap 8.49T, 6.6K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Bank Maspion Indonesia Tbk. is far larger — about 50.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (71K versus 6.6K). Which is the better fit depends on your goals.
| BMAS | OBAT | |
|---|---|---|
Market Cap | 8.49T | 167.37B |
Volume | 6.6K | 71K |
Lot | 66 | 710 |
Turnover | 3.12M | 17.51M |
Average Price | 472.15 | 246.63 |
Value | 3.12M | 17.51M |
Indicative Equilibrium Price | — | 246 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Maspion Indonesia Tbk (the Bank) was established on November 6, 1989 based on Notarial Deed No. 68 of Soetjipto, S.H., which was amended by Notarial Deed No. 49 dated December 5, 1989 of the same notary. The Bank started its commercial operations in 1990. As of December 31, 2012, the Bank has 10 domestic branches, 27 sub-branches, 10 cash offices and 45 Automatic Teller Machines (ATMs) located at Surabaya, Jakarta, Semarang, Denpasar, Medan, Bandung, Makassar, Malang, Solo and Purwokerto.
Read more on BMAS →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →